Coronavirus: Delhi, Hyderabad Airports Prepare to Receive First Batch of COVID-19 Vaccines from India: Center.
New Delhi:
With a jump of 32,080 new COVID-19 cases, the coronavirus case count in India reached 97.35 lakh in the last 24 hours, government data shows. The daily case count was nearly 21% higher than yesterday’s 26,567, the lowest since July 10. Last day, 402 people died from the viral disease that has claimed 1,41,360 lives in India so far. The country also conducted around 10 lakhs of testing in this period.
Here’s your 10-point cheat sheet for this great story:
-
Total active cases declined further to 3.78,909 as nearly 36,600 people recovered in the past 24 hours. With this, India’s overall recoveries have exceeded 92 lakh.
-
Coronavirus cases in India have declined steadily since the mid-September surge, the health ministry said, adding that active cases have dropped from 10 lakh on September 18 to 9 lakh on October 8, 8 lakh on October 16, 7 lakh in October. 22, 6 lakh on October 29, 5 lakh on November 10, and 4 lakh on December 6.
-
Kerala (5,032), Maharashtra (4,026), Delhi (3,188), West Bengal (2,941) and Rajasthan (1,604) continued to record the highest daily cases.
-
All of these states, except Rajasthan, also accounted for the highest daily deaths in the past 24 hours. Punjab replaced Rajasthan in fifth place with 30 deaths. Delhi had the highest deaths at 57. But, this was the fewest people to die from COVID-19 in Delhi since early November, a month in which the city recorded nearly 2,600 deaths.
-
Amid the third wave of infections in Delhi, the positivity rate fell to 3 percent on Monday from almost 5 percent last Thursday.
-
Lung and kidney problems are the most common complications related to Covid, confirms a large study, now published, of COVID-19 patients in the United States. According to the study, the absolute risk of someone with Covid having serious illnesses was 27.6% for pneumonia, 22.6% for respiratory failure, 11.8% for kidney failure, and 10.4% for sepsis or systemic inflammation.
-
With three vaccine candidates from Oxford, Pfizer and Bharat Biotech under active consideration for emergency use in India, the government has said that its existing cold chain facilities are capable of storing the first shipment of nearly three million new vaccines against coronaviruses that have been targeted at frontline healthcare and medical workers.
-
According to one study, the Oxford vaccine, which is being produced at the Serum Institute of India, was successful in preventing Covid-19 disease in most people infected with the virus, but showed only limited ability to stop transmission of the coronavirus.
-
The Serum Institute of India is about to sign a supply contract with the Center and is likely to set prices at Rs 250 per dose of vaccine. Its chief executive, Adar Poonawalla, had said that Serum will focus first on supplying the vaccine to Indians before distributing it to other countries.
-
Outgoing US President Donald Trump has signed an executive order prioritizing Americans’ access to COVID-19 vaccines before the US begins helping other nations. If necessary, Trump said, he is ready to invoke the Defense Production Act.
.
